2.72 (-%)
As of Nov 20, 2024
Source:
Hookipa Pharma Inc is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on our proprietary arenavirus platform that is designed to target and amplify T cell and immune responses to fight diseases.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 43 1 890 63 60 |
| Industry | manufacturing |
| CEO | Joern Aldag |
| Website | www.hookipapharma.com |